2027 ICD-10-CM Diagnosis Code D44.12Neoplasm of uncertain behavior of left adrenal gland
ICD-10-CM Codes›C00–D49›D37-D48›D44
- Billable — Valid for Submission
- Not Chronic
D44.12 is a billable ICD-10-CM diagnosis code for neoplasm of uncertain behavior of left adrenal gland. It is valid on HIPAA claims for fiscal year 2027 (October 1, 2026 through September 30, 2027) and groups to MS-DRG 643 through 645. Coders also document this condition as bilateral mass of adrenal glands. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Neoplasms of unspecified nature or uncertain behavior.
Code Identity
Code Classification
Approximate SynonymsGuidance
Alternate terms and clinical phrases that map to this code.
- Bilateral mass of adrenal glands
- Bilateral neoplasm of uncertain behavior of adrenal glands
- Neoplasm of uncertain behavior of adrenal gland
- Neoplasm of uncertain behavior of left adrenal gland
- Neoplasm of uncertain behavior of right adrenal gland
Instructional NotesGuidance
Instructions from the official ICD-10-CM Tabular List that apply to D44.12: its own notes plus those printed at D44.1, D44, block D37-D48, and Chapter 2. A note printed at a category, block or chapter applies to every code under it.
Excludes1
Not coded here: the excluded code is never reported together with this one, unless the two conditions are unrelated.
- neoplasms of unspecified behavior (D49.-)
Use Additional Code
Add a second code, after this one, to fully describe the condition.
- code to identify any functional activity.
Notes
General instructions on how these codes are used.
- Functional activity
- All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm.
- Morphology [Histology]
- Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes.
- Primary malignant neoplasms overlapping site boundaries
- A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned.
- Malignant neoplasm of ectopic tissue
- Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (C25.9).
Source: CMS ICD-10-CM Tabular List. How to read instructional notes.
Referenced in Other NotesGuidance
Instructional notes printed at other codes that name D44.12, its category, or a range that includes it.
Excludes2 1
These codes carry an Excludes2 note naming D44.12: its condition is not part of those codes, and both may be reported when the patient has both.
- D49 Neoplasms of unspecified behavior
Notes 1
These notes mention D44.12.
- Block D37-D48 Neoplasms of uncertain behavior, polycythemia vera and myelodysplastic syndromes
Clinical ClassificationClinical
AHRQ’s CCSR groups this code into broader clinical categories.
Table of NeoplasmsClinical
Anatomical sites in the Table of Neoplasms that reference this code family.
| Site | Malig. Primary | Malig. Secondary | Ca in situ | Benign | Uncertain | Unspec. |
|---|---|---|---|---|---|---|
| adrenal | C74.9 | C79.7 | D09.3 | D35.0 | D44.1 | D49.7 |
| adrenal › capsule | C74.9 | C79.7 | D09.3 | D35.0 | D44.1 | D49.7 |
| adrenal › cortex | C74.0 | C79.7 | D09.3 | D35.0 | D44.1 | D49.7 |
| adrenal › gland | C74.9 | C79.7 | D09.3 | D35.0 | D44.1 | D49.7 |
| adrenal › medulla | C74.1 | C79.7 | D09.3 | D35.0 | D44.1 | D49.7 |
| cortex › adrenal | C74.0 | C79.7 | D09.3 | D35.0 | D44.1 | D49.7 |
| medulla › adrenal | C74.1 | C79.7 | D09.3 | D35.0 | D44.1 | D49.7 |
| suprarenal | C74.9 | C79.7 | D09.3 | D35.0 | D44.1 | D49.7 |
| suprarenal › capsule | C74.9 | C79.7 | D09.3 | D35.0 | D44.1 | D49.7 |
| suprarenal › cortex | C74.0 | C79.7 | D09.3 | D35.0 | D44.1 | D49.7 |
| suprarenal › gland | C74.9 | C79.7 | D09.3 | D35.0 | D44.1 | D49.7 |
| suprarenal › medulla | C74.1 | C79.7 | D09.3 | D35.0 | D44.1 | D49.7 |
Patient EducationClinical
Adrenal Gland Disorders
Your adrenal glands are two small organs that sit on top of each kidney. The adrenal glands make different types of hormones you need to stay alive and healthy. Hormones are chemicals that travel in your bloodstream and control how different parts of your body work.
The full article covers:
- What are adrenal glands?
- What are adrenal gland disorders?
- What causes adrenal gland disorders?
- How are adrenal gland disorders diagnosed?
- What are the treatments for adrenal gland disorders?
Read the full article at MedlinePlus
Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.
Convert D44.12 to ICD-9-CMHistory
The closest ICD-9-CM equivalents under the General Equivalence Mappings.
Code HistoryHistory
Questions About D44.12Overview
What is the ICD-10 code for neoplasm of uncertain behavior of left adrenal gland?
The ICD-10-CM code for neoplasm of uncertain behavior of left adrenal gland is D44.12 (sometimes written as D4412). It is billable on HIPAA-covered claims from October 1, 2026 through September 30, 2027.
Is D44.12 (Neoplasm of uncertain behavior of adrenal gland) a billable code?
Yes. This is a billable ICD-10-CM code, specific enough to report neoplasm of uncertain behavior of left adrenal gland on HIPAA-covered claims from October 1, 2026 through September 30, 2027.
What MS-DRG does D44.12 group to?
When neoplasm of uncertain behavior of left adrenal gland is the principal diagnosis on an inpatient stay, it groups to MS-DRG 644, 645, 643, with relative weights from 0.7461 to 1.6138 depending on complications. Higher weights mean higher Medicare reimbursement.
Can D44.12 be reported with a code from E31.2?
Not as a rule. The Excludes1 note at D44, which applies to D44.12, lists "multiple endocrine adenomatosis (E31.2-)". An Excludes1 note means the excluded code is never reported together with this one; the only exception is when the two conditions are unrelated to each other (Official Guidelines, Section I.A.12.a).
Does D44.12 need an additional code?
When the condition applies, yes. The Use Additional Code note at D44.1, which applies to D44.12, reads: code to identify any functional activity.. The additional code is reported after D44.12.
